Difference between revisions of "GUILLAIN BARRE SYNDROME (GBS)-INVESTIGATIONS"
(Imported from text file) |
(Imported from text file) |
||
| Line 3: | Line 3: | ||
<br/> | <br/> | ||
<br/>2. NCS: abnormal after 1-2 weeks, abnormal SNAP, CMAP, F-wave. | <br/>2. NCS: abnormal after 1-2 weeks, abnormal SNAP, CMAP, F-wave. | ||
<br/> | |||
<br/>3. EMG: normal | <br/>3. EMG: normal | ||
<br/> | |||
<br/>4. Blood: anti-ganglioside antibodies present. GM-1 (40-50% of GBS), GQ1b (Miller Fisher variant). | <br/>4. Blood: anti-ganglioside antibodies present. GM-1 (40-50% of GBS), GQ1b (Miller Fisher variant). | ||
Latest revision as of 11:07, 20 March 2023
SUMMARY
1. Lumbar puncture: protein-cell (albumino-cytologic) dissociation with high protein concentration and normal WBC count. Protein can take a few days to become elevated. Inflammatory cells suggest alternative diagnosis.
2. NCS: abnormal after 1-2 weeks, abnormal SNAP, CMAP, F-wave.
3. EMG: normal
4. Blood: anti-ganglioside antibodies present. GM-1 (40-50% of GBS), GQ1b (Miller Fisher variant).
Reference(s)
Wilkinson, I., Furmedge, D. and Sinharay, R. (2017). Oxford handbook of clinical medicine. Oxford: Oxford University Press. Get it on Amazon.
Feather, A., Randall, D. and Waterhouse, M. (2020). Kumar And Clark’s Clinical Medicine. 10th ed. S.L.: Elsevier Health Sciences. Get it on Amazon.
Hannaman, R. A., Bullock, L., Hatchell, C. A., & Yoffe, M. (2016). Internal medicine review core curriculum, 2017-2018. CO Springs, CO: MedStudy.
Therapeutic Guidelines. Melbourne: Therapeutic Guidelines Limited. https://www.tg.org.au [Accessed 2021].
